Its been determined that IGF-1 is a single chain 70-amino acid polypeptide cross-linked by 3 disulfide bridges. It got its current name because it has certain insulin-like actions in the body (including lowering blood sugar), but it isnt nearly as powerful as insulin when it comes to controlling blood glucose levels
But heres the thing: There are no published clinical trials on GLP-1 microdosing in healthy adults
Back Holst, JJ (26 April 2019) 'From the Incretin Concept and the discovery of GLP-1 to today's diabetes therapy', Frontiers in Endocrinology , 10
The safest and smartest approach is to listen to what your body is telling you
This may include nutrition guidance, activity recommendations, and supportive treatments such as NAD+ injection therapy or other vitamin injections
However, the high cost of GLP-1 receptor agonists and limited access to these therapies in certain regions may act as restraining factors